🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to determine whether long-term (≥ 6 months at the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-03-27
Trial ID
NCT00303498
Treatments Being Tested
The safety and efficacy at 100 mg once daily for oral dose of sitaxentan so...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01210443
Treatments Being Tested
Endothelin-1 (ET-1) has been linked to a number of conditions including pul...
Status
Completed
Location
Clinical Research Centre, Western General Hospital
Start Date
2009-01
Trial ID
NCT01100736
Treatments Being Tested
This is a multi-center, open-label study of sitaxsentan sodium 100 mg taken...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2003-03
Trial ID
NCT00811018
Treatments Being Tested
Sitaxsentan has a low drug-drug interaction potential and it did not have a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01244620
Treatments Being Tested
Introduction. Despite adequate steroid therapy, a subpopulation of approxim...
Status
Terminated
Location
Clinical Investigation center 07, Hopital Bichat
Start Date
2009-11
Trial ID
NCT01050491
Treatments Being Tested
This is a multi-center, randomized study of sitaxsentan administered intrav...
Status
Completed
Location
University of Pennsylvania,
Start Date
2006-08-10
Trial ID
NCT00838383
Treatments Being Tested
This study will assess how rifampin will affect the blood levels of sitaxse...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01251835
Treatments Being Tested
The study is to assess if sitaxsentan and ritonavir will affect the blood l...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01251848
Treatments Being Tested
As monotherapy for pulmonary arterial hypertension (PAH) begins to fail add...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-05
Trial ID
NCT00796666
Treatments Being Tested